AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Thursday, October 17, 2019

In The News

As insurers continue to hold off on covering next-generation sequencing (NGS) tests for cancer tumors, pharmaceutical companies ranging from major players to smaller biotech companies are building their own line of genetic tests that target specific and rare tumors—cancer that responds to the respective drug treatments they offer.
Point-of-care testing (POCT) is poised to grow into a $30 billion industry worldwide by 2020, promising novel, wireless innovations that swiftly deliver results on routine and molecular laboratory tests. However, some roadblocks related to quality and reimbursement are stifling its path, according to POCT experts who spoke during an AACC-sponsored…

AACC Alert

Adjusting low-density lipoprotein (LDL) cholesterol measurements for lipoprotein(a), or Lp(a), cholesterol concentration improves the diagnostic accuracy of two key tools used to identify familial hypercholesterolemia (FH). These findings underscore that Lp(a) should be measured in all patients suspected of having FH, according to the authors of a study published in…

Practice Management

Acute kidney injury (AKI) alone, or in combination with chronic kidney disease (CK), significantly increases mortality risk in cirrhotic patients waiting for a liver transplant. A study published in Clinical Gastroenterology and Hepatology underscores the importance of assessing renal function patterns to improve risk profiles in these patients, setting the…

World View

A study published in JAMA Network Open demonstrated the feasibility of using advanced predictive algorithms to identify redundant tests in individual patient cases. This approach could take a bite out of a common problem in hospital settings, overutilization of low-value laboratory tests.